Titan Spine Receives Market Registration Approval In Australia And New Zealand For Its Endoskeleton® Interbody Fusion Devices

Published: Jun 25, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

MEQUON, Wis.--(BUSINESS WIRE)--Titan Spine, a medical device surface technology company focused on developing innovative spinal interbody fusion implants, today announced that it has received separate registration approval from both the Australian Therapeutic Goods Administration (TGA) and the New Zealand Medicines and Medical Devices Safety Authority (MEDSAFE) to commercially market its full line of Endoskeleton® interbody fusion devices in the two countries.

Help employers find you! Check out all the jobs and post your resume.

Back to news